Skip to main content
Download PDF

Head and neck cancer patients show poor oral health as compared to those with other types of cancer

BMC Oral Health volume 23, Article number: 647 (2023) Cite this article

Abstract

Purpose

Several studies have found associations between periodontitis and various types of cancer. Since the site of head and neck cancer (HNC) has contiguity or proximity to the oral cavity, it may be particularly influenced by oral inflammation. This study aimed to determine whether HNC patients have poor oral health as compared to those with other types of cancer.

Methods

This study retrospectively examined oral environmental factors including periodontal inflamed surface area (PISA), a new periodontal inflammatory parameter. A total of 1030 cancer patients were divided into the HNC (n = 142) and other cancer (n = 888) groups. Furthermore, the HNC group was divided into high (n = 71) and low (n = 71) PISA subgroups, and independent risk factors affecting a high PISA value were investigated.

Results

Multivariate logistic regression analysis showed that number of missing teeth (odds ratio 1.72, 95% CI 1.15–2.56, P < 0.01), PISA (odds ratio 1.06, 95% CI 1.03–1.06, P < 0.05), and oral bacterial count (odds ratio 1.02, 95% CI 1.01–1.03, P < 0.01) were independent factors related to HNC. In addition, multivariate logistic regression analysis indicated that current smoker (odds ratio 7.51, 95% CI 1.63–34.71, P < 0.01) and presence of untreated dental caries (odds ratio 3.33, 95% CI 1.23–9.00, P < 0.05) were independent risk factors affecting high PISA values in HNC patients.

Conclusion

HNC patients have higher levels of gingival inflammation and poor oral health as compared to patients with other types of cancer, indicating that prompt oral assessment and an effective oral hygiene management plan are needed at the time of HNC diagnosis.

Peer Review reports

Introduction

Several recent studies have indicated that periodontitis is associated with risk of various types of cancer. A systematic review and meta-analysis of subjects in the United States demonstrated that never smokers and individuals with periodontal disease have a higher risk of developing hematopoietic and lymphatic cancer [1]. In a case–control study, tooth loss and DMFT score results showed that dental caries was associated with risk of gastric adenocarcinoma [2]. Furthermore, periodontal disease was found to be related to increased breast cancer risk in a prospective cohort investigation of postmenopausal women [3], while a significant relationship between periodontitis and incidence of lung cancer was detailed in a systematic review and meta-analysis [4]. On the other hand, head and neck cancer (HNC) is the seventh most common cancer in the world, with the number of cases increasing each year in aging populations [5, 6]. HNC includes all malignancies of the upper aerodigestive tract, the majority of which are of mucosal origin, such as that arising from the paranasal sinuses, nasal cavity, oral cavity, naso-, oro-, and hypo-pharynx, and larynx [7]. Those sites have contiguity or proximity to the oral cavity and may be influenced by oral inflammatory disease [8]. Therefore, periodontitis may be associated with a greater risk for HNC as compared with other types of cancer.

Several other previous cohort and case–control studies, as well as meta-analyses have shown an association of HNC with periodontitis [9,10,11,12]. Those evaluated number of lost teeth, periodontal pocket depth, tooth mobility, oral hygiene, annual dentist visits, daily tooth brushing, and radiographic evidence of alveolar bone loss as parameters of periodontitis. However, those factors represent periodontal inflammation, both past and present, are used for determining the prognosis of individual teeth, while they may not be applicable as parameters for current inflammatory activity in periodontal tissues.

Periodontal inflamed surface area (PISA), a new index reported by Nesse et al., is used for quantification of the present inflammatory burden posed by periodontal disease and represents the sum of probing pocket depth in bleeding on probing (BOP)-positive sites for the complete dentition [13]. In recent reports, PISA values for investigating periodontitis in patients with ankylosing spondylitis were positively correlated with periodontal indexes, such as BOP, severity of periodontitis, frequency of Porphyromonas gingivalis detection, and presence of that bacterium in serum [14]. Additionally, PISA has been found to be associated with serum C-reactive protein (CRP) level, which indicates systemic inflammation, in septuagenarian patients [15, 16]. Thus, PISA is considered able to show present inflammatory activity in periodontal tissues.

We speculated that HNC patients have increased oral environmental risk factors as compared with other cancer patients. This study was conducted as a retrospective examination to analyze oral environmental factors including PISA in patients with HNC as compared to those with other types of cancer. In addition, independent risk factors with effects on high PISA values in HNC patients were investigated.

Materials and methods

Patients and methods

For this registry-based retrospective cohort study, the records of 1123 patients referred to our dental department from a medical department of Hiroshima University Hospital for oral care prior to undergoing chemotherapy for malignant tumors in the period from January 1, 2020 to March 31, 2021 were initially examined. The Strengthening the Reporting of Observational studies in Epidemiology (STROBE) guidelines were used as a checklist [17]. After excluding 93 with poor medical records or an inadequate intraoral examination, 1030 patients (619 males, 411 females) were enrolled, and divided into the HNC and other cancer groups (Fig. 1).

Fig. 1
figure 1

Flow chart showing patient selection for this study

Full size image

Baseline clinical characteristics for all enrolled patients, including age, gender, smoking status, alcohol consumption, hypertension, diabetes, hyperlipidemia, cerebrovascular disease, cardiovascular disease, history of malignancy, type of cancer, and frequency of dental visits, were collected from electronic medical records. Regarding smoking status, patients with a smoking habit within six months of their first visit were defined as current smokers, those who had quit smoking more than six months prior were defined as former smokers, and those who had never smoked were defined as never-smokers. Hypertension was defined as use of antihypertensive medication or a confirmed resting blood pressure of 140/90 mmHg or higher. Diabetes mellitus was defined as a glycated hemoglobin level of 6.5% or higher, fasting blood glucose level of 126 mg/dl or higher, or use of antidiabetic medication. Hyperlipidemia was defined as total cholesterol level of 220 mg/dl or higher, low-density lipoprotein cholesterol level of 140 mg/dl or higher, high-density lipoprotein cholesterol level of less than 40 mg/dl, triglyceride level of 150 mg/dl or higher, or use of antihyperlipidemic medication. Cerebrovascular disease was defined as history of ischemic stroke, while cardiovascular disease was defined as history of persistent or paroxysmal AF and history of ischemic heart disease, peripheral arterial disease, or congestive heart failure. The attending physician determined the diagnosis of cardiovascular disease.

Approval for this retrospective study (number E-453, registration date April 1, 2019) was obtained from the Epidemiology and Ethics Committee of Hiroshima University. All participants signed an informed consent agreement.

Oral examination

The enrolled patients were evaluated based on number of missing teeth, presence of untreated dental caries, and periodontal status noted on the day of their first visit for a dental examination, after referral from the medical department and prior to starting chemotherapy. Loss of  ≥ 6 teeth was defined as a tooth loss condition and considered to be associated with risk of HNC [18]. Periodontal inflamed surface area (PISA) was determined using the method reported by Nesse et al. and previous studies including our own [13, 14, 19,20,21,22]. All measurements were performed using fully erupted teeth at six sites per tooth with a Williams periodontal probe (HuFriedy, USA). Bleeding was recorded as either present or absent within 30 s of probing at all sites of each tooth. The intra-rater reliability of pocket probing was determined prior to the start of the present study. For that determination, probing depth was assessed at six sites (mesiobuccal, mesiolingual, buccal, lingual, distobuccal, distolingual) in three different subjects two separate times by a dentist. The calculated value of the intraclass correlation coefficient suggesting a reproducible assessment of pocket depth was found to be 0.80. PISA is based on the amount of probing pocket depth of sites with bleeding among the total dentition, whereas periodontal epithelial surface area (PESA) is the total amount of surface area of the periodontal pocket. PISA and PESA were calculated using a prepared spreadsheet (freely available from www.parsprototo.info), as previously described by Nesse et al. [13]. Oral bacterial measurements were determined with a device that provides quantification based on electrical impedance (Panasonic Healthcare Holdings Co., Ltd., Tokyo), according to previous reports [23, 24]. Samples were collected from the middle of the tongue surface using an exclusive applicator by a clinically experienced dental hygienist trained to minimize measurement errors. Oral bacterial counts were automatically determined by the device. Degree of xerostomia was determined using a Mucus oral moisture meter (Life Co., Ltd.) [25], with xerostomia defined based on a value  > 27, according to the manual provided by the manufacturer. Participants were queried regarding the frequency of dental visits, then categorized as “visited within one year” and “no visits for at least one year”.

Statistical analysis

All analyses were performed using the statistical software package JMP 12.2 (SAS Institute Inc., Cary, NC, USA). Values are expressed as average, median, and standard error (SE) when an associated variable was a continuous variable, or as frequency and percentage clinically when that was a discrete variable. Univariate analysis was performed to evaluate between-group differences in regard to baseline characteristics, risk factors, oral assessment measures, and frequency of dental visits for both the HNC and other cancer groups. Comparisons between groups were made using Student’s T-test or a Mann–Whitney U test to compare two unpaired groups, and Fisher's exact probability test or a chi-squared test.

Multivariate logistic regression analysis was used to assess independent effects on HNC. Variables with a P value  < 0.05 in univariate analysis were subjected to multivariate analysis using a forced entry method. A Hosmer–Lemeshow goodness-of-fit test was used to evaluate the fit of the model. Propensity score-matched analysis was performed to eliminate the effects of clinical confounding factors, which were calculated using logistic regression analysis of 10 clinical parameters (i.e., age, gender, smoking status, alcohol consumption, hypertension, diabetes, hyperlipidemia, stroke, heart disease, previous episode of malignant tumor). A caliper width of 0.25 for standard deviations of propensity score was used for analysis. Univariate analysis was performed to evaluate risk factors that affected high PISA values in the HNC group, which was divided into high and low PISA subgroups based on the median value of 213. Finally, covariates with a P value  < 0.05 in univariate analysis and history of DM related to PISA were subjected to multivariate analysis with a forced-entry method. All analyses were two-sided, with P values  < 0.05 considered to be statistically significant.

Results

Clinical characteristics of the 1030 patients retrospectively examined in this study are presented in Table 1. The mean age of the enrolled subjects was 64.3 ± 13.9 years. As for type of cancer, gastrointestinal cancer was the most common and noted in 274 cases, followed by hematological cancer in 180 and breast cancer in 150, while there were 142 cases of HNC. Similar to findings previously reported [26, 27], the HNC group had a significantly higher percentage of males, as well as patients with a history of smoking and drinking as compared to the others (P < 0.0001).

Table 1 Baseline clinical characteristics of cancer patients in this study (n = 1030)
Full size table

Following classification of the patients into the HNC (n = 142) and other cancer (n = 888) groups (Fig. 1), their clinical characteristics were compared. Results of univariate analysis of baseline characteristics to determine their association with HNC revealed gender, and smoking and drinking history to have significantly greater levels than other types of cancer (P < 0.0001) (Table 2).

Table 2 Comparison of clinical characteristics between HNC and other cancer groups
Full size table

Univariate analysis was also performed to compare clinical characteristics and oral environmental factors between the groups. Number of missing teeth, PISA, oral bacteria count, and xerostomia were significantly higher in the HNC group (P < 0.05, P < 0.001, P < 0.01, respectively), while presence of untreated dental caries, PESA, and frequency of dental visits was not significantly different between the groups (Table 3).

Table 3 Comparison of oral environmental factors between HNC and in other cancer groups
Full size table

Multivariate logistic regression analysis using the forced entry method was performed for variables with P values  < 0.05 shown in univariate analysis (Table 4). The Hosmer–Lemeshow test for the model had a P value of 0.66, indicating a good fit. Those results showed number of missing teeth (odds ratio 1.72, 95% CI 1.15–2.56, P < 0.01), PISA (odds ratio 1.06, 95% CI 1.03–1.06, P < 0.05), and bacterial count (odds ratio 1.02, 95% CI 1.01–1.03, P < 0.01) to be independent factors related to HNC (Table 4). Next, to reduce selection bias, propensity score-matching was used to identify 139 matched pairs in the HNC and other cancer groups. Propensity score matching between the HNC and other cancer groups was performed using propensity scores generated from the 10 clinical factors. A total of 278 patients (139 matched pairs) with propensity score matching were evaluated using univariate analysis. None of the 10 clinical variables differed significantly between the groups. Among oral environmental factors, PISA and the number of oral bacteria were significantly higher in the HNC as compared to the other cancer group (P < 0.05) (Table 5).

Table 4 Multivariate logistic regression analysis to identify risk factors associated with HNC
Full size table
Table 5 Comparison of clinical characteristics between HNC and other cancer groups after propensity score-matching
Full size table

PISA provides quantification of the present inflammatory burden posed by periodontal disease in individual subjects [13, 20]. To evaluate risk factors for a high PISA value in association with HNC, those patients were divided into the high (n = 71) and low (n = 71) PISA subgroups according to the median value of 213, then clinical characteristics and oral environmental factors were compared. Values for PESA were excluded, as those were explanatory variables not independent of PISA. Results of univariate analysis of risk factors with effects on a high PISA value in the HNC patients are presented in Table 6. Age, smoking status, and presence of untreated dental caries were significantly more frequent in the high as compared to low PISA subgroup (P < 0.005, P < 0.005, P < 0.0001, respectively). On the other hand, there were no significant differences in regard to gender, alcohol consumption, hypertension, diabetes, hyperlipidemia, stroke, heart disease, history of malignancy, missing teeth, oral bacterial count, xerostomia, or frequency of dental visits. The three explanatory variables with P values  < 0.05 in univariate analysis and also diabetes mellitus, as it has been reported to have a relationship with PISA [28], were then entered into multivariate logistic regression analysis using a forced entry method (Table 7). Those results showed current smoker (odds ratio 7.51, 95% CI 1.63–34.71, p = 0.0098) and presence of untreated caries (odds ratio 3.33, 95% CI 1.23–9.00, p = 0.0179) to be independent risk factors for high PISA in the present HNC patients.

Table 6 Comparison of clinical characteristics between low and high PISA subgroups of HNC patients
Full size table
Table 7 Multivariate logistic regression analysis to identify independent risk factors affecting high PISA value in HNC patients
Full size table

Discussion

For the present study, the assessment index PISA was utilized to compare periodontal inflammation between HNC and other types of cancer, which showed that PISA was significantly associated with HNC as compared to other types of cancer. PISA uses the sum of probing pocket depth of BOP-positive areas to determine present inflammatory burden, as gingival bleeding is an important sign of inflammation and supports identification of actively inflamed periodontal tissues, thus it can be utilized to distinguish between actively inflamed and non-inflamed or healed dentition [13, 20]. A recent report showed that PISA was associated with CRP level in serum samples obtained from septuagenarian subjects. CRP indicates systemic inflammation [29] and patients with severe periodontitis have been reported to have an increased level in serum [15, 16]. Therefore, PISA is considered to be a useful marker for estimating the effect of periodontitis on the whole body and considered to be more sensitive than severity detected in conventional periodontal examinations [19]. Oral epithelium disruption caused by development of periodontitis results in release of inflammatory cytokines, such as TNF and IL-1 β [30]. Those cytokines are generally detected in the first phase of carcinogenesis, and their overexpression promotes tumor formation and development of cancer [31, 32]. Periodontitis development can induce excessive production of reactive oxygen species from inflammatory cells, a type of oxidative stress known to be associated with DNA damage [8, 31]. Additionally, recent studies have shown a direct role of periodontal bacteria such as P. gingivalis in carcinogenesis [8, 33]. On the other hand, PESA was not significantly different between the HNC and other cancer groups. PESA accurately quantifies the surface area of pocket epithelium when the gingival margin is located at or below the cement enamel junction, and some parts that comprise PESA consist of healthy epithelium that does not contribute to inflammatory burden [14]. The results obtained in the present study indicate that HNC patients are presented with greater levels of gingival inflammation in periodontal tissues as compared with patients affected by other types of cancer, which may be associated with development and progression of HNC.

Univariate analysis results showed that PISA, number of missing teeth, oral bacterial count, and xerostomia were significantly associated with HNC as compared with other types of cancer in the present patients, while multivariate logistic regression analysis indicated that number of missing teeth, PISA, and bacterial count were independent factors related to HNC. In several previous cohort and case control studies, tooth loss was used as a surrogate parameter for periodontal disease and found to be a significant dependent risk factor for HNC [18]. Although number of missing teeth does not necessarily indicate the presence of periodontitis, it has been shown to be related to dental visits and a history of poor oral hygiene [34, 35]. On the other hand, oral bacterial count has been found to be dependent on oral hygiene condition such as xerostomia and have an influence on perioperative complications during cancer treatment [36]. Also, oral hygiene management during cancer treatment or palliative therapy has been reported to result in a decreased oral bacterial count and improve complications related to xerostomia [37, 38]. The present results indicate that HNC patients have worse oral hygiene as compared to patients with other types of cancer, thus prompt oral assessment and planning of oral hygiene management is needed at the time of HNC diagnosis.

Previous studies have shown that HNC is associated with periodontal diseases [9,10,11,12], which constantly contribute to systemic inflammation, resulting in increased plasma levels of proinflammatory cytokines, acute phase proteins, and other proteinases. Those inflammatory processes can generate free radicals and active intermediates, which causes oxidative stress related to DNA damage [8, 9]. Furthermore, periodontopathic bacteria have been reported to have a direct role in carcinogenesis development [8]. On the other hand, patients with cancer often have decreased levels of activities of daily living (ADL) and instrumental activities of daily living (IADL) [39]. Therefore, brushing deficiency due to a decrease in IADL related to onset of HNC may secondarily promote poor oral hygiene, thus leading to periodontal inflammation indicated by PISA. To elucidate the mechanism of the relationship of HNC with periodontal inflammation, oral environment factors such as oral hygiene condition and periodontal inflammation prior to the onset of HNC must be examined.

Current smoking status was found to be an independent risk factor related to a high PISA value in the present HNC patients. Smoking is known to be the most significant risk factor for HNC development [40, 41]. Additionally, smoking is known to affect mechanisms related to the pathogenesis and development of periodontal diseases, including decreasing gingival perfusion, which restricts nutrients and oxygen delivery, thus suppressing immune response, and inhibiting morphological and functional recovery of the periodontium, and increasing the infectivity of oral microbiota. These factors combine to promote disruption of wound healing and accelerate development of periodontal disease [42]. Some clinical and epidemiological studies have also shown that smokers have fewer gingival bleeding pockets, as well as a suppressive effect of smoking on gingival bleeding [43,44,45]. PISA indicates the surface area of bleeding pocket epithelium in square millimeters [13], thus the present results appear to contradict previous reports regarding the relationship of gingival bleeding and smoking. However, Park et al. demonstrated that the quantity of current smoking was related to increased PISA value in a dose-dependent manner [14]. The present findings indicating that a high PISA value is affected by current smoking in HNC patients may imply a relationship with development of HNC and periodontitis.

Untreated caries was also found to be an independent risk factor related to a high PISA value in the HNC group. Indeed, some cross-sectional studies have shown a positive association between prevalence of untreated dental caries and severity of periodontal disease [46, 47], with the latter report noting that caries and periodontal disease should generally be considered as related risk factors during oral hygiene maintenance conducted during a regular dental visit. Furthermore, untreated caries can increase plaque retention and predispose the patient to periodontal disease [48]. Oral hygiene management has been reported to prevent various complications, such as oral mucositis and infection, during treatment for HNC [49,50,51]. Thus, improvement of poor oral health by caries and periodontal treatments in HNC patients prior to undergoing cancer therapy can decrease gingival inflammation, and that may reduce complications related to cancer treatment.

A previous report noted that low socioeconomic status (SES) was a risk factor strongly associated with HCN, with current smoking more strongly associated with HCN among households with low income [52]. Furthermore, low SES has been shown to be related to dental caries, periodontal diseases, and poor oral hygiene [53,54,55]. Although the SES of the present HCN patients was not examined, low SES may be a risk factor for increased PISA in HNC patients.

The present investigation has several limitations. First, PISA shows the current periodontal inflammatory burden caused by periodontal disease but does not indicate inflammation occurring at the onset of head and neck cancer. While there are no known markers that show continuous periodontal inflammation from the onset of HNC, the large numbers of missing teeth and high PISA values noted in HNC patients suggest repeated occurrence of a high level of gingival inflammation. Second, a comparison of periodontal inflammation markers such as PISA between HNC patients and healthy subjects was not performed. On the other hand, comparisons of markers related to periodontitis between patients with various types of cancer and healthy subjects have been examined in previous studies, which showed that periodontitis is a risk factor related to cancer occurrence including HNC [1,2,3,4, 9,10,11,12]. Therefore, poor oral health and a high level of gingival inflammation may have a greater association with development and progression of HNC as compared to other cancer types. Third, PISA is a new periodontal index and still has a low degree of recognition. However, several investigators have recently shown associations with systemic disease, physical status, and onset of complication after cancer treatment [19, 21, 22, 56,57,58,59,60]. In the future, PISA may become a representative marker for examining the relationship between periodontitis and systemic diseases. Fourth, the present analysis has intrinsic limitations related to its retrospective nature, particularly regarding data completeness. Notably, even though human papillomavirus (HPV) infection is a risk factor for HNC, detection of HPV16 DNA or E6/E7mRNA expression in oropharyngeal swab samples from affected patients was not performed [61, 62]. Fifth, this was a single-center study, which limits generalization of the findings. Sixth, the present results are limited by use of multiple comparisons. Factors that showed a P value  < 0.05 in univariate analysis and clinically relevant factors were subjected to multivariate logistic regression analysis. Causal factors can be shown in such analysis results by chance when several variables are examined together. Finally, it has been reported that oral bacterial count determined with the device used in the present study is associated with complications occurring after surgery for cardiovascular disease and during chemotherapy for breast cancer [24, 36]. However, differences regarding bacterial species on the tongue surface between patients with HNC and other types of cancer were not clarified in the present study. An investigation performed to identify specific bacteria related to HNC is needed.

In conclusion, this is the first known study to demonstrate that PISA, number of missing teeth, and oral bacteria count were significantly associated with HNC as compared with other types of cancer. Furthermore, smoking and untreated caries were shown to be independent risk factors affecting a high PISA value in HNC cases. Patients with HNC are often presented with a high level of periodontal inflammation and poor oral hygiene as compared with those with other cancer types. Therefore, prompt oral assessment and planning of oral hygiene management is necessary at the time of HNC diagnosis.

Availability of data and materials

Raw data obtained in this study are not publicly available due to ethical restrictions, though are available for any author who wishes to collaborate with the present authors.

References

  1. Wu Y, Shi X, Li Y, et al. Hematopoietic and lymphatic cancers in patients with periodontitis: a systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2020;25:e21–8. https://doi.org/10.4317/medoral.23166.

    Article  PubMed  Google Scholar 

  2. Shakeri R, Malekzadeh R, Etemadi A, et al. Association of tooth loss and oral hygiene with risk of gastric adenocarcinoma. Cancer Prev Res. 2013;6:477–82. https://doi.org/10.1158/1940-6207.CAPR-12-0491.

    Article  Google Scholar 

  3. Freudenheim JL, Genco RJ, LaMonte MJ, et al. Periodontal disease and breast cancer: prospective cohort study of postmenopausal women. Cancer Epidemiol Biomark Prev. 2016;25:43–50. https://doi.org/10.1158/1055-9965.EPI-15-0750.

    Article  Google Scholar 

  4. Wang J, Yang X, Zou X, et al. Relationship between periodontal disease and lung cancer: a systematic review and meta-analysis. J Periodont Res. 2020;55:581–93. https://doi.org/10.1111/jre.12772.

    Article  Google Scholar 

  5. Dhull AK, Atri R, Dhankhar R, et al. Major risk factors in head and neck cancer a retrospective analysis of 12-year experiences. World J Oncol. 2018;9:80–4. https://doi.org/10.14740/wjon1104w.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Vahl JM, Wigand MC, Denkinger M, et al. Increasing mean age of head and neck cancer patients at a german tertiary referral center. Cancers. 2021;13:1–10. https://doi.org/10.3390/cancers13040832.

    Article  Google Scholar 

  7. Cognetti DM, Weber RS, Lai SY. Head and neck Cancer an evolving treatment paradigm. Cancer. 2008;113:1911–32. https://doi.org/10.1002/cncr.23654.

    Article  PubMed  Google Scholar 

  8. Gopinath D, Menon RK, Veettil SK, et al. Periodontal diseases as putative risk factors for head and neck cancer: systematic review and meta-analysis. Cancers. 2020;12:1–15. https://doi.org/10.3390/cancers12071893.

    Article  Google Scholar 

  9. Tezal M, Sullivan MA, Hyland A, et al. Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomark Prev. 2009;18:2406–12. https://doi.org/10.1158/1055-9965.EPI-09-0334.

    Article  Google Scholar 

  10. Garrote LF, Herrero R, Reyes RMO, et al. Risk factors for cancer of the oral cavity and oro-pharynx in Cuba. Br J Cancer. 2001;85:46–54. https://doi.org/10.1054/bjoc.2000.1825.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Hashim D, Sartori S, Brennan P, et al. The role of oral hygiene in head and neck cancer: results from International Head and Neck Cancer Epidemiology (INHANCE) consortium. Ann Oncol. 2016;27:1619–25. https://doi.org/10.1093/annonc/mdw224.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Zeng XT, Deng AP, Li C, et al. Periodontal disease and risk of head and neck cancer: a meta-analysis of observational studies. https://doi.org/10.1371/journal.pone.0079017.

  13. Nesse W, Abbas F, Van Der Ploeg I, et al. Periodontal inflamed surface area: quantifying inflammatory burden. J Clin Periodontol. 2008;35:668–73. https://doi.org/10.1111/j.1600-051X.2008.01249.x.

    Article  PubMed  Google Scholar 

  14. Park SY, Ahn S, Lee JT, et al. Periodontal inflamed surface area as a novel numerical variable describing periodontal conditions. J Periodontol Implant Sci. 2017;47:328–38. https://doi.org/10.5051/jpis.2017.47.5.328.

    Article  Google Scholar 

  15. Linden GJ, McClean K, Young I, et al. Persistently raised C-reactive protein levels are associated with advanced periodontal disease. J Clin Periodontol. 2008;35:741–7. https://doi.org/10.1111/j.1600-051X.2008.01288.x.

    Article  PubMed  Google Scholar 

  16. Noack B, Genco RJ, Trevisan M, et al. Periodontal infections contribute to elevated systemic c-reactive protein level. J Periodontol. 2001;72:1221–7. https://doi.org/10.1902/jop.2000.72.9.1221.

    Article  PubMed  Google Scholar 

  17. Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13:S31–4. https://doi.org/10.4103/sja.SJA_543_18.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Zeng XT, Luo W, Huang W, et al. Tooth loss and head and neck cancer: a meta-analysis of observational studies. PLoS One. 2013;8:1–8. https://doi.org/10.1371/journal.pone.0079074.

    Article  Google Scholar 

  19. Miki K, Kitamura M, Hatta K, et al. Periodontal inflamed surface area is associated with hs-CRP in septuagenarian Japanese adults in cross-sectional findings from the SONIC study. Sci Rep. 2021;11:1–8. https://doi.org/10.1038/s41598-021-93872-8.

    Article  Google Scholar 

  20. Benjamin A, Paralkar S. Periodontal Inflamed Surface Area ( PISA ) as a measure of quantifying inflamed tissue - A Review. World J Adv Sci Res. 2018;1:106–13.

    Google Scholar 

  21. Fkl S. Dose-response relationship between periodontal inflamed surface area and HbA1c in type 2 Diabetics. J Clin Periodontol. 2009;36:295–300. https://doi.org/10.1111/j.1600-051X.2009.01377.x.

    Article  Google Scholar 

  22. Nishi H, Ohta K, Kuramoto Y, et al. Periodontal inflamed surface area in oral cavity associated with febrile neutropenia in patients with hematologic malignancy undergoing chemotherapy. Sci Rep. 2022;12:1–9. https://doi.org/10.1038/s41598-022-06485-0.

    Article  Google Scholar 

  23. Hamada R, Suehiro J, Nakano M, et al. Development of rapid oral bacteria detection apparatus based on dielectrophoretic impedance measurement method. IET Nanobiotechnol. 2011;5:25–31. https://doi.org/10.1049/iet-nbt.2010.0011.

    Article  PubMed  Google Scholar 

  24. Suzuki K, Sasada S, Nishi H, et al. Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy. Breast Cancer. 2023;30:151–5. https://doi.org/10.1007/s12282-022-01410-9.

    Article  PubMed  Google Scholar 

  25. Murakami M, Nishi Y, Kamashita Y, Nagaoka E. Relationship between medical treatment and oral dryness diagnosed by oral moisture-checking device in patients with maxillofacial prostheses. J Prosthodont Res. 2009;53:67–71. https://doi.org/10.1016/J.JPOR.2008.08.010.

    Article  PubMed  Google Scholar 

  26. Cohen N, Fedewa S, Chen AY. Epidemiology and demographics of the head and neck cancer population. Oral Maxillofac Surg Clin North Am. 2018;30:381–95. https://doi.org/10.1016/J.COMS.2018.06.001.

    Article  PubMed  Google Scholar 

  27. Hashim D, Genden E, Posner M, et al. Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden. Ann Oncol. 2019;30:744–56. https://doi.org/10.1093/ANNONC/MDZ084.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Nesse W, Linde A, Abbas F, et al. Dose–response relationship between periodontal inflamed surface area and HbA1c in type 2 Diabetics. J Clin Periodontol. 2009;36:295–300. https://doi.org/10.1111/j.1600-051X.2009.01377.x.

    Article  PubMed  Google Scholar 

  29. Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375:132–40. https://doi.org/10.1016/S0140-6736(09)61717-7.

    Article  PubMed  Google Scholar 

  30. Pan W, Wang Q, Chen Q. The cytokine network involved in the host immune response to periodontitis. Int J Oral Sci. 2019;11. https://doi.org/10.1038/s41368-019-0064-z.

  31. Soory M. Oxidative stress induced mechanisms in the progression of periodontal diseases and cancer: a common approach to redox Homeostasis? Cancers. 2010;2:670–92. https://doi.org/10.3390/cancers2020670.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436–44. https://doi.org/10.1038/nature07205.

    Article  PubMed  Google Scholar 

  33. Xiao L, Zhang Q, Peng Y, et al. The effect of periodontal bacteria infection on incidence and prognosis of cancer. Medicine. 2020;99:e19698. https://doi.org/10.1097/md.0000000000019698.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Bhat M, Do LG, Roberts-Thomson K. Association between dental visiting and missing teeth: estimation using propensity score adjustment. J Investig Clin Dent. 2018;9:e12326. https://doi.org/10.1111/jicd.12326.

    Article  PubMed  Google Scholar 

  35. Meyer MS, Joshipura K, Giovannucci E, Michaud DS. A review of the relationship between tooth loss, periodontal disease, and cancer. Cancer Causes Control. 2008;19:895–907. https://doi.org/10.1007/s10552-008-9163-4.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Osako R, Matsuda Y, Itohara C, et al. Relationship between oral bacterial count and postoperative complications among patients with cardiovascular disease treated by surgery: a retrospective cohort study. Healthcare (Switzerland). 2021;9. https://doi.org/10.3390/healthcare9070850.

  37. Kawano T, Shigeishi H, Fukada E, et al. Changes in bacterial number at different sites of oral cavity during perioperative oral care management in gastrointestinal cancer patients: preliminary study. J Appl Oral Sci. 2018;26:1–12. https://doi.org/10.1590/1678-7757-2017-0516.

    Article  Google Scholar 

  38. Wu TY, Liu HY, Wu CY, et al. Professional oral care in end-of-life patients with advanced cancers in a hospice ward: improvement of oral conditions. BMC Palliat Care. 2020;19:1–15. https://doi.org/10.1186/s12904-020-00684-0.

    Article  Google Scholar 

  39. Neo J, Fettes L, Gao W, et al. Disability in activities of daily living among adults with cancer: a systematic review and meta-analysis. Cancer Treat Rev. 2017;61:94–106. https://doi.org/10.1016/j.ctrv.2017.10.006.

    Article  PubMed  Google Scholar 

  40. Morse DE, Psoter WJ, Cleveland D, et al. Smoking and drinking in relation to oral cancer and oral epithelial dysplasia. Cancer Causes Control. 2007;18:919–29. https://doi.org/10.1007/s10552-007-9026-4.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Viswanath A, Kerns TJ, Sorkin JD, et al. Self-reported oral cancer screening by smoking status in Maryland: trends over time. J Public Health Dent. 2013;73:261–70. https://doi.org/10.1111/jphd.12012.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Matthews JB, Chen FM, Milward MR, et al. Neutrophil superoxide production in the presence of cigarette smoke extract, nicotine and cotinine. J Clin Periodontol. 2012;39:626–34. https://doi.org/10.1111/j.1600-051X.2012.01894.x.

    Article  PubMed  Google Scholar 

  43. Bergström J, Eliasson S, Dock J. Exposure to tobacco smoking and periodontal health. J Clin Periodontol. 2000;27:61–8. https://doi.org/10.1034/j.1600-051x.2000.027001061.x.

    Article  PubMed  Google Scholar 

  44. Preber HBJ. Occurrence of gingival bleeding in smoker and non-smoker patients. Acta Odontol Scand. 1985;43:315–20. https://doi.org/10.3109/00016358509046515. PMID: 3878653.

    Article  PubMed  Google Scholar 

  45. Shimazaki Y, Saito T, Kiyohara Y, et al. The influence of current and former smoking on gingival bleeding: the hisayama study. J Periodontol. 2006;77:1430–5. https://doi.org/10.1902/jop.2006.050422.

    Article  PubMed  Google Scholar 

  46. Strauss F, Espinoza I, Stähli A, et al. Dental caries is associated with severe periodontitis in Chilean adults : a cross- sectional study. BMC Oral Health. 2019;2(19):1–8. https://doi.org/10.1186/s12903-019-0975-2.

    Article  Google Scholar 

  47. Durand R, Roufegarinejad A, Chandad F, et al. Dental caries are positively associated with periodontal disease severity. Clin Oral Invest. 2019;23:3811–9. https://doi.org/10.1007/s00784-019-02810-6.

    Article  Google Scholar 

  48. Axelsson P, Lindhe J, Nyström B. On the prevention of caries and periodontal disease. J Clin Periodontol. 1991;18:182–9. https://doi.org/10.1111/j.1600-051X.1991.tb01131.x.

    Article  PubMed  Google Scholar 

  49. Sroussi HY, Epstein JB, Bensadoun RJ, Saunders DP, Lalla RV, Migliorati CA, Heaivilin NZZ. Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med. 2017;6:2918–31. https://doi.org/10.1002/cam4.1221.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Kawashita Y, Soutome S, Umeda MST. Oral management strategies for radiotherapy of head and neck cancer. Jpn Dent Sci Rev. 2020;56:62–7. https://doi.org/10.1016/j.jdsr.2020.02.001.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Catalano A, Dansero L, Gilcrease W, Macciotta A, Saugo C, Manfredi L, Gnavi R, Strippoli E, Zengarini N, Caramello V, Costa G, Sacerdote CRF. Multimorbidity and SARS-CoV-2-related outcomes: analysis of a cohort of italian patients. JMIR Public Health Surveill. 2023;9:9. https://doi.org/10.2196/41404.

    Article  Google Scholar 

  52. Stanford-Moore G, Bradshaw PT, Weissler MC, et al. Interaction between known risk factors for head and neck cancer and socioeconomic status: the Carolina Head and Neck Cancer Study. Cancer Causes Control. 2018;29:863–73. https://doi.org/10.1007/s10552-018-1062-8.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Costa SM, Martins CC, de Bonfim MLC, et al. A systematic review of socioeconomic indicators and dental caries in adults. Int J Environ Res Public Health. 2012;9:3540–74. https://doi.org/10.3390/ijerph9103540.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Borrell LN, Beck JD, Heiss G. Socioeconomic disadvantage and periodontal disease: the dental atherosclerosis risk in communities study. Am J Public Health. 2006;96:332–9. https://doi.org/10.2105/AJPH.2004.055277.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Oliveira MB, Lopes FF, Rodrigues VP, et al. Association between socioeconomic factors, behavioral, general health and oral mucosa status in elderly. Cien Saude Colet. 2018;23:3663–74. https://doi.org/10.1590/1413-812320182311.26182016.

    Article  PubMed  Google Scholar 

  56. Yamashita M, Kobayashi T, Ito S, Kaneko C, Murasawa A, Ishikawa H, Tabeta K. The periodontal inflamed surface area is associated with the clinical response to biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a retrospective study. Mod Rheumatol. 2020;30:990–6. https://doi.org/10.1080/14397595.2019.1680100.

    Article  PubMed  Google Scholar 

  57. Anil K, Vadakkekuttical RJ, Radhakrishnan C, Parambath FC. Correlation of periodontal inflamed surface area with glycemic status in controlled and uncontrolled type 2 diabetes mellitus. World J Clin Cases. 2021;9:11300–10. https://doi.org/10.12998/wjcc.v9.i36.11300.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Adhenkavil Radhakrishnan R, Joseph Vadakkekuttical R, Radhakrishnan C. Proportion and severity of periodontitis and correlation of periodontal inflamed surface area with glycemic status in patients with type 2 diabetic neuropathy with and without diabetic foot. J Periodontol. 2022;93:687–96. https://doi.org/10.1002/JPER.21-0174.

    Article  PubMed  Google Scholar 

  59. Mikami R, Mizutani K, Matsuyama Y, et al. Association between periodontal inflammation and serum lipid profile in a healthy population: a cross-sectional study. J Periodontal Res. 2021;56:1037–45. https://doi.org/10.1111/jre.12917.

    Article  PubMed  Google Scholar 

  60. Temelli B, Yetkin Ay Z, Aksoy F, et al. Platelet indices (Mean platelet volume and platelet distribution width) have correlations with periodontal inflamed surface area in coronary artery disease patients: a pilot study. J Periodontol. 2018;89:1203–12. https://doi.org/10.1002/JPER.17-0684.

    Article  PubMed  Google Scholar 

  61. Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagué X, Laporte L, Bosch FX, de Sanjosé STH. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol. 2014;15:1319–31. https://doi.org/10.1016/S1470-2045(14)70471-1.

    Article  PubMed  Google Scholar 

  62. Shigeishi HSM. Risk factors for oral human papillomavirus infection in healthy individuals: a systematic review and meta-analysis. J Clin Med Res. 2016;8:721–9.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank all the staff of Hiroshima University Hospital who were dedicated to providing the best care for the patients in this study.

Funding

This work was supported by a research grant from JSPS KAKENHI to Hiromi Nishi. (Grants-in-Aid for Scientific Research No. 20K101620A).

Author information

Authors and Affiliations

  1. Department of General Dentistry, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-Ku, Hiroshima, 734-8553, Japan

    Hiromi Nishi, Syuichi Munenaga & Hiroyuki Kawaguchi

  2. Department of Dental Hygiene, Ogaki Women’s College, Gifu, Japan

    Taiji Obayashi

  3. Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

    Tsutomu Ueda & Takashi Kono

  4. Department of Public Oral Health, Program of Oral Health Sciences, Hiroshima University, Hiroshima, Japan

    Kouji Ohta & Hideo Shigeishi

  5. Department of Molecular Oral Medicine and Maxillofacial Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

    Yukio Yoshioka

  6. Department of Oral and Maxillofacial Radiology, Hiroshima University Hospital, Hiroshima, Japan

    Masaru Konishi

  7. Department of Program of Dentistry, School of Dentistry, Hiroshima University, Hiroshima, Japan

    Ryotaro Taga & Yuya Toigawa

  8. Department of Oral and Maxillofacial Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

    Takako Naruse

  9. Department of Orthodontics and Craniofacial Developmental Biology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

    Eri Ishida, Eri Tsuboi, Kanae Oda & Kotaro Tanimoto

  10. Department of Clinical Practice and Support, Hiroshima University Hospital, Hiroshima, Japan

    Kana Dainobu & Tomoko Tokikazu

  11. Department of Oral and Maxillofacial Radiology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

    Naoya Kakimoto

  12. Department of Infectious Diseases, Hiroshima University Hospital, Hiroshima, Japan

    Hiroki Ohge

  13. Department of Periodontal Medicine, Division of Applied Life Sciences, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

    Hidemi Kurihara

Authors
  1. Hiromi Nishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Taiji Obayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tsutomu Ueda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kouji Ohta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hideo Shigeishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Syuichi Munenaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Takashi Kono
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yukio Yoshioka
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Masaru Konishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ryotaro Taga
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yuya Toigawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Takako Naruse
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Eri Ishida
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Eri Tsuboi
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Kanae Oda
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Kana Dainobu
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Tomoko Tokikazu
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Kotaro Tanimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Naoya Kakimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Hiroki Ohge
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Hidemi Kurihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. Hiroyuki Kawaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Hiromi Nishi, Taiji Obayashi, and Kouji Ohta conceived and designed the study. Hiromi Nishi, Taiji Obayashi, Tsutomu Ueda, Shuichi Munenaga, Takashi Kono, Yukio Yoshioka, Masaru Konishi, Ryotaro Taga, Yuya Toigawa, Takako Naruse, Eri Ishida, Eri Tsuboi, Kanae Oda, Kana Dainobu, Tomoko Tokikazu, and Naoya Kakimoto performed the experiments. Hiromi Nishi, Taiji Obayashi, Hideo Shigeishi, Ryotaro Taga, and Yuya Toigawa analyzed the obtained data. Kouji Ohta, Hideo Shigeishi, Kotaro Tanimoto, Hiroki Ohge, Hidemi Kurihara, and Hiroyuki Kawaguchi supervised the project. Hiromi Nishi wrote the manuscript. All authors have reviewed the final version of the manuscript and approved its submission for publishing.

Corresponding author

Correspondence to Hiromi Nishi.

Ethics declarations

Ethical approval and consent to participate

This study was approved by the Epidemiology and Ethics Committee of Hiroshima University (IRB approval number: E-453) and conducted in compliance with the Declaration of Helsinki 2013.Informed consent was obtained from all individual participants included in the study.

Consent for publication

Written informed consent for publication of identifying information was obtained from the patients.

Competing interests

The authors have no potential conflicts of interest relevant to this work to declare in regard to authorship or publication of this article.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

Supplemental Data 1. Comparisons of clinical characteristics between oral/oropharyngeal and other cancer type groups including HNC without oral/oropharyngeal cancer. Supplemental Data 2. Comparisons of oral environmental factors between oral/oropharyngeal and other cancer type groups including HNC without oral/oropharyngeal cancer. Supplemental Data 3. Multivariate logistic regression analysis to identify risk factors associated with oral/oropharyngeal cancer. Supplemental Data 4. Comparisons of clinical characteristics and oral environmental factors between oral/oropharyngeal cancer group and HNC without oral/oropharyngeal cancer group.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nishi, H., Obayashi, T., Ueda, T. et al. Head and neck cancer patients show poor oral health as compared to those with other types of cancer. BMC Oral Health 23, 647 (2023). https://doi.org/10.1186/s12903-023-03356-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12903-023-03356-6

Keywords

BMC Oral Health

ISSN: 1472-6831

Contact us